A Treatment-as-Prevention Trial to Eliminate Hepatitis C Among Men Who Have Sex With Men Living With Human Immunodeficiency Virus (HIV) in the Swiss HIV Cohort Study
Author(s) -
Dominique L. Braun,
Benjamin Hampel,
Bruno Ledergerber,
Christina Grube,
Huyen Nguyen,
Patrizia KünzlerHeule,
Cyril Shah,
Luisa SalazarVizcaya,
Anna Conen,
Markus Flepp,
M Stöckle,
Charles Béguelin,
Patrick Schmid,
Mathieu Rougemont,
Julie Delaloye,
Enos Bernasconi,
Dunja Nicca,
Jürg Böni,
Andri Rauch,
Roger D. Kouyos,
Huldrych F. Günthard,
Jan Fehr
Publication year - 2020
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/ciaa1124
Subject(s) - medicine , human immunodeficiency virus (hiv) , cohort , men who have sex with men , cohort study , sida , viral disease , virology , gerontology , immunology , syphilis
In 2016, the World Health Organization (WHO) introduced global targets for the elimination of hepatitis C virus (HCV) by 2030. We conducted a nationwide HCV micro-elimination program among men who have sex with men (MSM) living with human immunodeficiency virus (HIV) from the Swiss HIV Cohort Study (SHCS) to test whether the WHO goals are achievable in this population.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom